secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2021-08-09T23:59:59+00:00
Accession:  0001140361-21-027569
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Michael Bonney resigns from Bristol-Myers board to become Executive Chairman of Alnylam
--------------------------------------------------------------------------------

- Bonney resigned effective August 3, 2021, in connection with his appointment as Executive Chairman of Alnylam Pharmaceuticals.
- Board set number of directors at ten, down from the prior size (not specified).
- No other changes to board composition or officer positions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036121027569/0001140361-21-027569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036121027569/brhc10027837_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-027569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer